To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901
NCT06171880 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2023-12-15
Summary
To evaluate the safety and pharmacokinetic characteristics after the administration of JC-001 and JLP-1901
Conditions
- Healthy Adult
Interventions
- DRUG
-
JLP-1901
administration of JLP-1901
- DRUG
-
JC-001(active comparator)
administration of JC-001(tenofovir)
Sponsors & Collaborators
-
Jeil Pharmaceutical Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-02-15
- Primary Completion
- 2022-03-11
- Completion
- 2022-05-13
Countries
- South Korea
Study Locations
More Related Trials
-
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults
NCT06931327 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers
NCT03774355 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers
NCT05155995 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.
NCT05191563 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety of IN-M00007 and IN-R00007 in Healthy Adult Volunteers
NCT07311811 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Pharmacokinetic Study of JNJ-42756493 in Healthy Participants
NCT02218073 ·Status: COMPLETED ·Phase: PHASE1
-
A Crossover Study to Evaluate Relative Bioavailability of Two JNJ-54781532 Tablet Formulations in Healthy Adult Participants
NCT02117505 ·Status: COMPLETED ·Phase: PHASE1
-
PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
NCT07144176 ·Status: RECRUITING ·Phase: PHASE1
-
To Compare Safety and Pharmacokinetic Properties of CJ-30039 and Lipidil Supra
NCT01501435 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Bioavailability, Safety and Tolerability of a Solid Dosage Formulation Relative to a Suspension of JNJ-54175446 in Healthy Male and Female Participants
NCT02930694 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety Profiles After Administration of DA-5221_01 and Co-administration of 5221_01-R1 and DA-5221_01-R2 in Healthy Adult Volunteers
NCT06616883 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Pharmacokinetic Study to Assess the Influence of Simultaneous CYP3A4 and P-glycoprotein Inhibition on E7080 Pharmacokinetics Following Single Dose Oral Administration of 5 mg E7080 to Healthy Volunteers
NCT02198170 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Pharmacokinetics and Safety of Oral Administration of BR9001 Compared With BR900A in Healthy Subjects
NCT03718611 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
NCT06000891 ·Status: TERMINATED ·Phase: PHASE1
-
Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers
NCT05132049 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Relative Bioavailability of Orally Administered JNJ-42756493 Tablet Versus JNJ-42756493 Capsule in Healthy Participants
NCT02231489 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Safety, Tolerability, and Pharmacokinetics of CC-92480 Formulations in Healthy Adult Participants
NCT04839809 ·Status: COMPLETED ·Phase: PHASE1
-
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
NCT05029518 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers
NCT06346184 ·Status: COMPLETED ·Phase: PHASE1
-
A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers
NCT07162441 ·Status: RECRUITING ·Phase: PHASE1
-
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults
NCT06933459 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects
NCT04081857 ·Status: COMPLETED ·Phase: PHASE1
-
Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fed State
NCT05739877 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase 1 Study To Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of A Modified-Release (MR) Formulation Of Tofacitinib In Healthy Volunteers
NCT01731327 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women
NCT04418388 ·Status: COMPLETED ·Phase: PHASE1